First Trust Nasdaq Pharmaceuticals ETF
FTXH
8 hedge funds and large institutions have $594K invested in First Trust Nasdaq Pharmaceuticals ETF in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
14% more funds holding
Funds holding: 7 → 8 (+1)
23.02% less ownership
Funds ownership: 33.17% → 10.15% (-23%)
45% less capital invested
Capital invested by funds: $1.08M → $594K (-$486K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$247K |
| 2 |
SMFS
Squar Milner Financial Services
Irvine,
California
|
+$117K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$60.3K |
| 4 |
MWPCG
Measured Wealth Private Client Group
Portsmouth,
New Hampshire
|
+$46.4K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$11.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$983K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $248K | +$247K | +10,650 | New |
|
|
SMFS
2
Squar Milner Financial Services
Irvine,
California
| $132K | +$117K | +5,050 | +856% |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $84K | +$60.3K | +2,600 | +272% |
|
4
Bank of America
Charlotte,
North Carolina
| $49K | +$2.32K | +100 | +5% |
|
|
MWPCG
5
Measured Wealth Private Client Group
Portsmouth,
New Hampshire
| $47K | +$46.4K | +2,000 | New |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $16K | +$6.54K | +282 | +72% |
|
|
SWP
7
Stratos Wealth Partners
Beachwood,
Ohio
| $12K | +$11.6K | +501 | New |
|
|
APA
8
American Portfolios Advisors
Holbrook,
New York
| $5.87K | – | – | – |
|
|
9
Jane Street
New York
| – | -$983K | -45,294 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$6K | -266 | Closed |
|
FTXH Hedge Fund Activity: Q3 2018 in Review
8 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q3 2018, worth a combined $594K — down 45% from $1.08M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FTXH positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $247K. The largest seller was Jane Street, exiting entirely with an estimated $983K sold.
- 8 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q3 2018, up from 7 in Q2 2018.
- Funds reported $594K of First Trust Nasdaq Pharmaceuticals ETF stock for Q3 2018, down 45% quarter-over-quarter.
- 3 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q3 2018 and 2 closed out, a net change of +1 holder.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q3 2018 was Citadel Advisors, an estimated $247K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q3 2018 was Jane Street, an estimated $983K sold.
Based on aggregated 13F filings for Q3 2018.